Guselkumab
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 992 publications
The Drug Update: Recent drug approvals, winter 2026 edition.
Journal: The Nurse practitioner
Published: January 22, 2026
Drug Survival of Biologics in Bionaive and Bioexperienced Patients With Psoriasis.
Journal: JAMA dermatology
Published: January 07, 2026
Generalised granuloma annulare following ustekinumab therapy for palmoplantar psoriasis.
Journal: BMJ case reports
Published: December 31, 2025
Biologics and Small-Molecule Inhibitors in Nummular Dermatitis: A Systematic Review.
Journal: Journal of cutaneous medicine and surgery
Published: December 26, 2025
What is the optimal sequential therapy after secondary IL-17A inhibitor failure in psoriasis: switching to an IL-23 inhibitor or to another IL-17A inhibitor?
Journal: The Journal of dermatological treatment
Published: December 11, 2025
Efficacy and safety of IL-23p19 and IL-12/23p40 inhibitors in moderate-to-severe Crohn's disease: a systematic review and network meta-analysis.
Journal: Annals of medicine
Published: December 03, 2025
Validity and Psychometric Properties of 3 and 4 Visual Analog Scale in Participants With Psoriatic Arthritis Treated With Guselkumab.
Journal: The Journal of rheumatology
Published: December 01, 2025
An evaluation of guselkumab for the treatment of ulcerative colitis.
Journal: Expert opinion on biological therapy
Published: December 01, 2025
Navigating the Misdiagnosis of Pityriasis Rubra Pilaris and Successful Treatment With Guselkumab: A Case Report of Dual Biologic Therapy.
Journal: Cureus
Published: November 29, 2025
Systematic Review and Network Meta-Analysis: Evaluating the Impact of advanced therapies for Moderate-to-Severe Ulcerative Colitis on Health-Related Quality of Life.
Journal: Journal of Crohn's & colitis
Published: November 24, 2025
Last Updated: 02/24/2026